Dual-Function Antibody PD-1/CTLA-4 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital20 enrolled1 locationNCT07306286
Recruiting
Phase 2
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital20 enrolled1 locationNCT07306273